In this ODwire.org webinar, Melissa Barnett, OD and Susan Resnick, OD will help us learn more about ptosis, including causes, diagnosis, treatment landscape, impact on patients, and opportunity for your practice.
Jason Bacharach, MD, will introduce the first and only FDA-approved pharmacologic treatment for acquired blepharoptosis, RVL-1201 (oxymetazoline hydrochloride ophthalmic solution), 0.1%, including its mechanism of action and clinical data.
A LIVE Q&A will follow, so please come with questions!
Learn more at http://curemydisorder.com/links/improve-eyesight-tedmaser-site